摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

piperazine-1-carboxylic acid phenethyl ester | 438046-91-4

中文名称
——
中文别名
——
英文名称
piperazine-1-carboxylic acid phenethyl ester
英文别名
2-phenylethyl piperazine-1-carboxylate
piperazine-1-carboxylic acid phenethyl ester化学式
CAS
438046-91-4
化学式
C13H18N2O2
mdl
——
分子量
234.298
InChiKey
LJXPTWOZQAWFAE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    371.8±30.0 °C(Predicted)
  • 密度:
    1.124±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    41.6
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    piperazine-1-carboxylic acid phenethyl ester 在 palladium on activated charcoal 盐酸4-二甲氨基吡啶氢气碳酸氢钠三乙胺 作用下, 以 1,4-二氧六环二氯甲烷 为溶剂, 生成 4-[(2S,3R)-2-Carboxy-3-(3-guanidino-propyl)-4-oxo-azetidine-1-carbonyl]-piperazine-1-carboxylic acid phenethyl ester
    参考文献:
    名称:
    Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors
    摘要:
    A series of N1-activated C4-carboxy azetidinones was prepared and tested as inhibitors of human tryptase. The key stereochemical and functional features required for potency, serine protease specificity and aqueous stability were determined. From these studies compound 2, BMS-262084, was identified as a potent and selective tryptase inhibitor which, when dosed intratracheally in ovalbumin-sensitized guinea pigs, reduced allergen-induced bronchoconstriction and inflammatory cell infiltration into the lung. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00688-1
  • 作为产物:
    参考文献:
    名称:
    Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors
    摘要:
    A series of N1-activated C4-carboxy azetidinones was prepared and tested as inhibitors of human tryptase. The key stereochemical and functional features required for potency, serine protease specificity and aqueous stability were determined. From these studies compound 2, BMS-262084, was identified as a potent and selective tryptase inhibitor which, when dosed intratracheally in ovalbumin-sensitized guinea pigs, reduced allergen-induced bronchoconstriction and inflammatory cell infiltration into the lung. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00688-1
点击查看最新优质反应信息

文献信息

  • Novel piperazine derivatives
    申请人:——
    公开号:US20020143020A1
    公开(公告)日:2002-10-03
    The present invention is a chemical compound of formula (I) 1 or a pharmaceutically acceptable salts, solvates and esters thereof, wherein R 1 to R 4 , A 1 , A 2 m and n are as described in the specification.
    本发明是一种具有公式(I)的化学化合物 1 或其药物可接受的盐、溶剂化物和酯,其中R 1 至R 4 ,A 1 ,A 2 ,m和n如说明书中所述。
  • Beta lactam compounds and their use as inhibitors of tryptase
    申请人:Bristol-Myers Squibb Co.
    公开号:US06335324B1
    公开(公告)日:2002-01-01
    Compounds of the formulas: are disclosed. These compounds inhibit tryptase as well as other enzyme systems or are selective tryptase inhibitors and are useful as antiinflammatory agents particularly in the treatment of chronic asthma.
    这些化合物的结构式已被披露。这些化合物抑制色胺蛋白酶以及其他酶系统,或者是选择性色胺酸蛋白酶抑制剂,并且在特别是治疗慢性哮喘方面作为抗炎药物是有用的。
  • PIPERAZINE DERIVATIVES
    申请人:F. Hoffmann-La Roche AG
    公开号:EP1343775B1
    公开(公告)日:2008-06-04
  • US7022707B2
    申请人:——
    公开号:US7022707B2
    公开(公告)日:2006-04-04
  • [EN] PIPERAZINE DERIVATIVES<br/>[FR] DERIVES DE PIPERAZINE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2002048124A2
    公开(公告)日:2002-06-20
    The present invention refers to chemical compounds of formula (I) as well as pharmaceutically usable salts, solvates and esters thereof, wherein R?1 to 44, A1, A2¿ m and n have the significance given in claim 1. They can be used in the form of pharmaceutically preparations for the treatment or prevention of disorders of the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.
查看更多